<--- Back to Details
First PageDocument Content
Blood / Coagulation system / Peripheral membrane proteins / Von Willebrand disease / Coagulation / Factor IX / Bleeding / Clinical trial / Partial thromboplastin time / Haemophilia / Medicine / Health
Blood
Coagulation system
Peripheral membrane proteins
Von Willebrand disease
Coagulation
Factor IX
Bleeding
Clinical trial
Partial thromboplastin time
Haemophilia
Medicine
Health

CDER Clinical Review Template

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 801,77 KB

Share Document on Facebook

Similar Documents

Blood / Medicine / Anatomy / Transfusion medicine / Hematology / Blood products / Coagulation system / Platelet / Blood transfusion / Hematocrit / Bleeding / Blood type

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

DocID: 1riKA - View Document

Cell biology / Biology / Blood / Programmed cell death / Apoptosis / Coagulation system / Cell signaling / Induced stem cells / Caspase / Platelet / Thrombopoiesis / Angiogenesis

Microsoft Wordfile00

DocID: 1r9dZ - View Document

Blood / Coagulation system / Anatomy / CSL Behring / Von Willebrand disease / Factor VIII / Coagulation / CSL Limited / Hereditary angioedema / Haemophilia / Factor IX / Factor VII

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

Medicine / Coagulation system / Thrombin / Antibody / Syringe / Surgical suture / Draft:Professor Dr. S Tsakas II

RECOTHROM, Thrombin topical (Recombinant) Package Insert

DocID: 1qv5K - View Document

Finance / Money / Economy / Transfusion medicine / Blood products / Corporate finance / Venture capital / Coagulation system / Platelet / Nesta / Bleeding / Seed money

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

DocID: 1qk7W - View Document